• Study on Atorvastatin for Patients with Early Breast Cancer

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study of Clenbuterol vs Placebo in Adult Patients with Spinal and Bulbar Muscular Atrophy (SBMA)

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Study on Dexamethasone for Patients with Herpes Simplex Virus Encephalitis

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study of Chemotherapy with Osimertinib in Non-Small Cell Lung Cancer Patients Who Have Progressed After Initial Osimertinib Treatment

    Not recruiting

    3 1 1
    Investigated drugs:
    Germany Italy Spain

  • Study on the Safety and Effectiveness of Trifluridine/Tipiracil, Capecitabine, and Bevacizumab for Patients with Metastatic Colorectal Cancer Unfit for Intensive Chemotherapy

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Study of Pembrolizumab with Hyaluronidase for Patients with Relapsed or Refractory Hodgkin Lymphoma or Primary Mediastinal Large B-cell Lymphoma

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Poland Spain

  • Study of Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone for Treating Multiple Myeloma Patients with Extramedullary Disease

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Greece Italy

  • Study on the Effectiveness and Safety of Vosoritide for Children with Hypochondroplasia

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy Spain

  • A study comparing TAP block versus QL block with ropivacaine for pain management after laparoscopic colon resection in patients with colon cancer or diverticulosis

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Finland

  • Study of BT8009 Alone or with Pembrolizumab for Patients with Advanced or Metastatic Bladder Cancer

    Not recruiting

    2 1 1 1
    Investigated drugs:
    Austria Belgium Bulgaria Czechia Denmark France +12

powered by